3rd Quarter - Report

FAEGRE BAKER DANIELS CONSULTING for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmacy regulation; DEA Clearinghouse Act of 2018

LobbyistCovered position, as disclosed
LIBBY BANEY —
MARY BONO Member of Congress, California 1998-2012
BEENA PATEL —

Contacted: HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Management & Budget (OMB); SENATE; Food & Drug Administration (FDA)

Health Issues HCR

Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act

LobbyistCovered position, as disclosed
LIBBY BANEY —
MARY BONO Member of Congress, California 1998-2012
BEENA PATEL —

Contacted: Food & Drug Administration (FDA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Bills named: H.R. 6 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.